Short-Term Outcome of Dual Induction Therapy With Basiliximab and Low-Dose Rituximab in Kidney Transplant Recipients.

被引：0
|
作者：
Koyama, I. [1 ]
Iwadoh, K. [1 ]
Ogawa, Y. [1 ]
Soeno, M. [1 ]
Miki, K. [1 ]
Kai, K. [1 ]
Sannomiya, A. [1 ]
Murakami, T. [1 ]
Kitajima, K. [1 ]
Nakajima, I. [1 ]
Fuchinoue, S. [1 ]
机构：
[1] Tokyo Womens Med Univ, Kidney Ctr, Dept Surg, Tokyo, Japan
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01963
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C1806
引用
收藏
页码：582 / 582
页数：1
相关论文
共 50 条
  • [1] Short-Term Outcome of Dual Induction Therapy With Basiliximab and Low-Dose Rituximab in Kidney Transplant Recipients.
    Koyama, I.
    Iwadoh, K.
    Ogawa, Y.
    Soeno, M.
    Miki, K.
    Kai, K.
    Sannomiya, A.
    Murakami, T.
    Kitajima, K.
    Nakajima, I.
    Fuchinoue, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 582 - 582
  • [2] Induction Therapy with Low-Dose Rituximab Could Be a Risk Factor of BKV Associated Nephropathy in Kidney Transplant Recipients.
    Murakami, R.
    Nagawa, D.
    Nakata, M.
    Narita, I.
    Fujita, T.
    Shimada, M.
    Nakamura, N.
    Tomita, H.
    Hatakeyama, S.
    Yoneyama, T.
    Hashimoto, Y.
    Koie, T.
    Ohyama, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 831 - 831
  • [3] Excellent Outcomes by Low-Dose Rituximab Induction Therapy for Virtual Crossmatch (VCXM)-Positive Kidney Transplant Recipients.
    Tanabe, Kazunari
    Ishida, Hideki
    Omoto, Kazuya
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Furusawa, Miyuki
    Tokumoto, Tadahiko
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 562 - 562
  • [4] Short-Term Outcome Prediction Model in Deceased Donor Kidney Transplant Recipients.
    Archer, K.
    Zhang, Y.
    Bontha, S.
    Akalin, E.
    Gallon, L.
    Maluf, D.
    Mas, V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 664 - 664
  • [5] Single-Dose Basiliximab Induction Therapy in Low-Immunologic Risk Kidney Transplant Recipients
    Hutchins, A.
    Schoen, J.
    McMullen, J. S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 433 - 434
  • [6] Basiliximab versus T-cell Depleting Induction Therapy in Elderly Kidney Transplant Recipients.
    Vranic, G.
    Shah, H.
    Thomas, B.
    Javaid, B.
    Moore, J.
    Cooper, M.
    Gilbert, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 560 - 561
  • [7] Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial
    Martinez-Mier, Gustavo
    Moreno-Ley, Pedro, I
    Budar-Fernandez, Luis F.
    Mendez-Lopez, Marco T.
    Allende-Castellanos, Carlos A.
    Jimenez-Lopez, Luis A.
    Barrera-Amoros, Daniel A.
    Aguilar-Sandoval, Edgar
    De la Paz-Roman, Maritza
    Soto-Miranda, Ernesto
    Rivera-Sanchez, Yamilli
    Martinez-Maldonado, Monica
    [J]. TRANSPLANTATION PROCEEDINGS, 2021, 53 (03) : 1005 - 1009
  • [8] Comparison of Transplant Outcomes for Low-Dose and Standard-Dose Tacrolimus in Kidney Transplant Recipients.
    Cho, J. -H.
    Kim, K.
    Kim, M.
    Do, W.
    Yang, Y.
    Yim, T.
    Hwang, I.
    Lee, J. -H.
    Kwon, E.
    Jung, H. -Y.
    Choi, J. -Y.
    Park, S. -H.
    Kim, Y. -L.
    Kim, C. -D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 541 - 541
  • [9] Short-Term Outcome of Everolimus and Mizoribine Based CNI Minimization Immunosuppressant Therapy for De Novo Kidney Transplant Recipients.
    Nishioka, T.
    Nose, K.
    Sugimoto, K.
    Matsumura, N.
    Hayashi, T.
    Ishii, T.
    Uemura, H.
    [J]. TRANSPLANTATION, 2014, 98 : 549 - 550
  • [10] Use of Thymoglobulin in Low Dose Schemes as Induction Therapy in High Risk Kidney Transplant Recipients.
    Perez-Vega, D.
    Rojas-Campos, E.
    Salvador, M. -C.
    Evangelista-Carrillo, L.
    Molina-Ruiz, F.
    Gomez-Navarro, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 318 - 318
12345